BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12387034)

  • 1. [Sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy with sulfonylurea and alpha-glucosidase inhibitor].
    Iijima T
    Nihon Rinsho; 1997 Nov; 55 Suppl():186-91. PubMed ID: 9434465
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic profile of oral antidiabetic agents].
    Okubo M; Yamane K; Kohno N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():310-6. PubMed ID: 12387011
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
    Kitaoka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():447-51. PubMed ID: 12387032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indication and side effect of alpha glucosidase inhibitor].
    Katahira H; Ishida H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():399-408. PubMed ID: 12387025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of voglibose, alpha-glucosidase inhibitor in treatment of impaired glucose tolerance].
    Nakamura J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():457-61. PubMed ID: 15779422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
    Kawamori R; Kadowaki T; Ishida H
    Nihon Rinsho; 2004 Apr; 62(4):831-9. PubMed ID: 15106356
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.
    Yamazaki K; Inoue T; Yasuda N; Sato Y; Nagakura T; Takenaka O; Clark R; Saeki T; Tanaka I
    J Pharmacol Sci; 2007 May; 104(1):29-38. PubMed ID: 17485917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapies for newly-onset diabetic patients].
    Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological treatment of type 2 diabetes.
    Hermans MP; Buysschaert M
    Acta Clin Belg; 2004; 59(2):59-66. PubMed ID: 15224468
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of voglibose on daily glycemic excursions assessed by the "J"-index in non-insulin dependent diabetes mellitus.
    Yoshioka K; Azukari K; Ashida K; Kasamatsu Y; Yokoo S; Yoshida T; Kondo M
    Horm Metab Res; 1997 Aug; 29(8):407-8. PubMed ID: 9288580
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of an alpha-glucosidase inhibitor (voglibose), in combination with sulphonylureas, on glycaemic control in type 2 diabetes patients.
    Saito N; Sakai H; Suzuki S; Sekihara H; Yajima Y
    J Int Med Res; 1998; 26(5):219-32. PubMed ID: 9924706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K; Kawamori R
    Nihon Rinsho; 1997 Nov; 55 Suppl():261-6. PubMed ID: 9434478
    [No Abstract]   [Full Text] [Related]  

  • 16. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
    Odaka H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():393-8. PubMed ID: 12387024
    [No Abstract]   [Full Text] [Related]  

  • 17. Troglitazone combination therapy in obese type 2 diabetic patients poorly controlled with alpha-glucosidase inhibitors.
    Bando Y; Ushiogi Y; Okafuji K; Toya D; Tanaka N; Fujisawa M
    J Int Med Res; 1999; 27(2):53-64. PubMed ID: 10446691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an alpha-glucosidase inhibitor and insulin on glucose metabolism and lipid profiles in non-insulin-dependent diabetes mellitus.
    Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
    J Int Med Res; 1996; 24(5):438-47. PubMed ID: 8895048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a very low dose of tolbutamide combined with an alpha-glucosidase inhibitor in non-insulin-dependent diabetes mellitus.
    Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
    J Int Med Res; 1996; 24(5):433-7. PubMed ID: 8895047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.